inhalable COVID-19 antibody therapy
Scope
Date
~
-
Economy
S.Korea's Engel coefficient rises sharply amid COVID-19 pandemic
South Korea’s low-income households are feeling the pinch of rising food prices amid the COVID-19 pandemic, according to a report by a local t...
Feb 17, 2023 (Gmt+09:00)
-
Aerospace & Defense
KAI expects 2023 sales to grow by a third, driven by fighter jets
Korea Aerospace Industries Ltd. (KAI), South Korea’s sole military aircraft manufacturer, said on Wednesday it aims to achieve 3.83 trillion w...
Feb 15, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
S.Korean shipbuilders rule world’s eco-friendly vessel market
South Korea’s shipbuilders have won more than half of the orders to build eco-friendly vessels so this year based on advanced technology to do...
Feb 14, 2023 (Gmt+09:00)
-
Automobiles
Electric vehicles in S.Korea beat diesel cars in sales
Sales of electric vehicles (EVs) in South Korea last year including hybrids surpassed those of diesel cars for the first time due to the price of di...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Companies
China's alleged Korean trademark piracy surges during COVID-19
South Korean companies have witnessed a sharp increase in alleged trademark piracy in China over the past few years, as COVID-19 curbed their overse...
Feb 07, 2023 (Gmt+09:00)
-
Retail
Galleria Dept. Store's sales from foreigners increase 500% for past 6 months
South Korea's department store group Galleria Department Store said on Tuesday that for the past six months (between August last year and January th...
Feb 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Airlines
Jeju Air to resume flights on Incheon-Shizuoka route in March
Jeju Air Co., a South Korean budget airline, said on Thursday that it would resume its flights connecting Incheon with two small cities in Japan, Ma...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Real estate
Hotels in top Seoul tourist area on sale due to rate hikes
South Korea's KB Asset Management Co. is set to sell two three-star hotel buildings in Myeong-dong, one of the most popular spots for foreign touris...
Jan 04, 2023 (Gmt+09:00)
-
Airlines
Korean LCCs cancel China-bound flights due to COVID-19
Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Travel & Leisure
Korea's int'l passenger traffic exceeds domestic for 1st time since pandemic
The volume of international passengers in South Korea has exceeded that of domestic flights for the first time since the outbreak of the COVID-19 pa...
Dec 26, 2022 (Gmt+09:00)
-
Airlines
Korea-China air flights set to rise with Beijing’s eased zero-COVID policy
Air flights between South Korea and China are set to rise significantly next year with the Chinese government issuing new guidelines easing its stri...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Perspectives
China’s COVID reopening poses risks and opportunities
News that Beijing is finally scrapping its growth-killing “zero COVID” policy seems the equivalent of answered prayers for Asia. And it co...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's 2021 bio sector output $15.4 bn; 5-year annual growth 20%
South Korea's bio industry last year exceeded 20 trillion won ($15.4 billion) in production for the first time and continues to see strong growth.Th...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
PCL’s diagnostic kit measures concentration of COVID-19 antibodies
PCL Inc., a South Korean in vitro diagnostics device maker, plans to bring two test kits – one that simultaneously detects COVID-19 and influenza infe...
Dec 08, 2022 (Gmt+09:00)
-
Korean SMEs
Korean ministry, Incheon airport to develop distribution center for SMEs
The Korea SMEs and Startup Agency (KOSME) and Incheon International Airport Corp. (IIAC) on Wednesday announced their signing of a contract to bui...
Nov 24, 2022 (Gmt+09:00)
-
Travel & Leisure
MZers drive Korea's indoor golf facility pandemic boom
Indoor golf facilities’ revenue in South Korea has skyrocketed amid the pandemic, thanks to millennials and Generation Zers' soaring consumpti...
Nov 21, 2022 (Gmt+09:00)
-
Airlines
S. Korea's T'way Air to resume Incheon-Chiang Mai route
South Korea's budget carrier T'way Air on Wednesday said it will resume from Nov. 28 its flight linking Incheon and Chiang Mai, Thailand, with seven...
Nov 17, 2022 (Gmt+09:00)
-
Korean startups
South Korea’s biggest startup event ComeUp 2022 kicks off in Seoul
South Korea’s largest startup event ComeUp kicked off on Wednesday at the Dongdaemun Design Plaza (DDP). The annual event, which celebrat...
Nov 09, 2022 (Gmt+09:00)